YUM
45
-5
USB
64
-9
PSA
43
-10
ROP
53
-4
SCHW
64
-7
LOW
56
-3
RRC
70
-2
EQT
56
-3
MET
66
-7
WDC
61
-5
WYNN
38
-4
URI
58
-7
PWR
76
-2
HSY
24
-3
OXY
42
-3
DVA
49
-5
CMI
56
-4
PRGO
44
-2
WMT
60
-6
HPQ
63
-4
YUM
45
-5
USB
64
-9
PSA
43
-10
ROP
53
-4
SCHW
64
-7
LOW
56
-3
RRC
70
-2
EQT
56
-3
MET
66
-7
WDC
61
-5
WYNN
38
-4
URI
58
-7
PWR
76
-2
HSY
24
-3
OXY
42
-3
DVA
49
-5
CMI
56
-4
PRGO
44
-2
WMT
60
-6
HPQ
63
-4
Financhill
Back

Ascendis Pharma AS Stock Price Chart

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
32

ASND
Ascendis Pharma AS

Last Price:
$158.38
Seasonality Move:
2.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Portfolio's Boring. This Company Isn't And It's Early

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
  • The current trend is moderately bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.

Ascendis Pharma AS Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 158.54 Sell
20-day SMA: 161.98 Sell
50-day SMA: 157.94 Buy
200-day SMA: 140.08 Buy
8-day EMA: 159.26 Sell
20-day EMA: 159.56 Sell
50-day EMA: 156.31 Buy
200-day EMA: 143.37 Buy

Ascendis Pharma AS Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.39 Buy
Relative Strength Index (14 RSI): 48.82 Sell
Chaikin Money Flow: -236955 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (156.66 - 166.64) Sell
Bollinger Bands (100): (133.58 - 161.82) Buy

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Ascendis Pharma AS Stock

Is Ascendis Pharma AS Stock a Buy?

  • Ascendis Pharma AS share price is 158.10 while ASND 8-day simple moving average is 158.54, which is a Sell signal.
  • The stock price of ASND is 158.10 while Ascendis Pharma AS 20-day SMA is 161.98, which makes it a Sell.
  • Ascendis Pharma AS 50-day simple moving average is 157.94 while ASND share price is 158.10, making it a Buy technically.
  • ASND stock price is 158.10 and Ascendis Pharma AS 200-day simple moving average is 140.08, creating a Buy signal.

ASND Technical Analysis vs Fundamental Analysis

Sell
32
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy or a Sell?

Ascendis Pharma AS Stock Info

Market Cap:
9.6B
Price in USD:
158.10
Share Volume:
396.9K

Ascendis Pharma AS 52-Week Range

52-Week High:
183.00
52-Week Low:
111.09
Sell
32
Ascendis Pharma AS (ASND) is a Sell

Ascendis Pharma AS Share Price Forecast

Is Ascendis Pharma AS Stock a Buy?

  • Ascendis Pharma AS share price is 158.10 while ASND 8-day exponential moving average is 159.26, which is a Sell signal.
  • The stock price of ASND is 158.10 while Ascendis Pharma AS 20-day EMA is 159.56, which makes it a Sell.
  • Ascendis Pharma AS 50-day exponential moving average is 156.31 while ASND share price is 158.10, making it a Buy technically.
  • ASND stock price is 158.10 and Ascendis Pharma AS 200-day simple moving average is 143.37, creating a Buy signal.

Fundamental Analysis of Ascendis Pharma AS

Is Ascendis Pharma AS a good investment?

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.59 per share, an increase this year of $2.02 per share, and an increase next year of $7.29 per share.

Technical Analysis of Ascendis Pharma AS

Should I short Ascendis Pharma AS stock?

* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.